Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Adenotonsillectomy and adenoidectomy in children: The impact of timing of surgery and post-operative outcomes.

Authors:
Francisco J Schneuer Katy Jl Bell Chris Dalton Adam Elshaug Natasha Nassar

J Paediatr Child Health 2022 Jun 3. Epub 2022 Jun 3.

The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Aim: To investigate the impact of adenotonsillectomy (ADT) and adenoidectomy (AD) on child health and evaluated their post-operative complications.

Methods: We included all children aged <16 years undergoing ADT (tonsillectomy ± adenoidectomy) or AD in New South Wales, Australia, 2008-2017. Health information was obtained from administrative hospitalisation data. Rates of post-operative complications and reoperation were evaluated using generalised estimating equations and Kaplan-Meier methods, respectively.

Results: Out of 156 500 included children, 112 361 had ADT and 44 139 had AD. Population rates increased during 2008-2017 (ADT: 68-79 per 10 000 children; AD: 25-34 per 10 000), and children were increasingly operated on at a younger age. Overall, 7262 (6.5%) and 1276 (2.9%) children had post-operative complications (mostly haemorrhage), and 4320 (3.8%) and 5394 (12.2%) required reoperation, following ADT and AD, respectively. Complication rates were highest among children aged 0-1 years, lowest for those 2-5 years and increased with age thereafter. Three-year reoperation rates for children aged 0-1 years were 9.0% and 25.9% following ADT and AD, respectively, decreasing thereafter to 0.5% and 2.1% in children aged 12-13 years.

Conclusions: ADT and AD in Australian children have both increased in frequency and are being done at a younger age. Post-operative complications and reoperation rates highlight surgery is not without risk, especially for children under 2 years old. These findings support a more conservative approach to management of upper respiratory symptoms, with surgery reserved for cases where potential benefits are most likely to outweigh harms.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpc.16052DOI Listing
June 2022

Publication Analysis

Top Keywords

children aged
4
outcomes aim
4
included children
4
complicationsmethods included
4
post-operative complicationsmethods
4
evaluated post-operative
4
health evaluated
4
child health
4
adenoidectomy child
4
adt adenoidectomy
4
adenotonsillectomy adt
4
adenotonsillectomy adenoidectomy
4
investigate impact
4
aim investigate
4
impact adenotonsillectomy
4
children impact
4
post-operative outcomes
4
surgery post-operative
4
adenoidectomy children
4
timing surgery
4

Keyword Occurance

Similar Publications

Multilevel analysis of grand multiparity: Trend and its determinants in the Sidama National Regional State of Ethiopia: a cross-sectional study design from demographic and health survey 2000-2016.

Authors:
Tamirat Tesfaye Dasa Michael A Okunlola Yadeta Dessie

BMJ Open 2022 Aug 16;12(8):e061697. Epub 2022 Aug 16.

Public Health, Haramaya University College of Health and Medical Sciences, Haramaya, Oromia, Ethiopia.

Objective: The study was aimed at examining the magnitude, trends and determinants of grand multiparity in the Sidama regional state of Ethiopia.

Design: We retrieved cross-sectional data from the Ethiopia Demographic and Health Survey from 2000 to 2016.

Setting: Community-based demographic and health survey (DHS) was conducted in Ethiopia. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Participant Characteristics and Safety Outcomes of Peanut Oral Immunotherapy in the RAMSES and ARC011 Trials.

Authors:
Christina Ciaccio Alan B Goldsobel Aikaterini Anagnostou Kirsten Beyer Thomas B Casale Antoine Deschildre Montserrat Fernández-Rivas Jonathan O'B Hourihane Marta Krawiec Jay Lieberman Amy M Scurlock Brian P Vickery Alex Smith Stephen A Tilles Daniel C Adelman Kari R Brown

Ann Allergy Asthma Immunol 2022 Aug 13. Epub 2022 Aug 13.

Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, USA. Electronic address:

Background: Clinical trials (PALISADE [ARC003], ARTEMIS [ARC010]) proving efficacy and safety of peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) used double-blind, placebo-controlled food challenges (DBPCFCs) to screen for eligibility and to evaluate efficacy. In routine clinical practice, individuals with peanut allergy do not always undergo food challenges to confirm diagnosis or determine candidacy for treatment.

Objective: To describe PTAH safety/tolerability in participants selected by clinical history and peanut sensitization parameters not undergoing DBPCFC during trails and to compare findings with previously published data. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Exposure to organophosphorus compounds of Japanese children and the indoor air quality in their residences.

Authors:
Toshiaki Yoshida Mayumi Mimura Naomi Sakon

Sci Total Environ 2022 Aug 13:158020. Epub 2022 Aug 13.

Osaka Institute of Public Health, 1-3-69, Nakamichi, Higashinari-ku, Osaka 537-0025, Japan.

Several organophosphorus compounds such as organophosphate pesticides (OPPs) and trialkylphosphates (TAPs) are suspected to inhibit cholinesterase activities, to affect endocrine systems or to possibly be carcinogenic. To evaluate their adverse effects on health with chronic exposure in the general population, especially in children, we measured the household exposure to OPPs and TAPs by Japanese children via all exposure pathways and the contribution of indoor air quality. First-morning void urine was collected from subjects aged 6 to 15 years (n = 132), and airborne organophosphorus compounds were sampled in the subject's bedroom for 24 h. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Exploring the role of exposure to green and blue spaces in preventing anxiety and depression among young people aged 14-24 years living in urban settings: A systematic review and conceptual framework.

Authors:
Isabelle Bray Rebecca Reece Danielle Sinnett Faith Martin Robert Hayward

Environ Res 2022 Aug 13:114081. Epub 2022 Aug 13.

University of the West of England, Bristol, UK.

Despite the growing problem of anxiety and depression amongst young people aged 14-24 years living in urban settings, reviews about the role of exposure to green and blue spaces or nature in preventing anxiety and depression tend to focus on children, adults or sometimes adolescents. This review aims to explore whether exposure to green and blue spaces reduces the risk of anxiety and depression among young people aged 14-24 years living in urban settings and provide a conceptual framework. The academic databases CINAHL plus, Global Health, MEDLINE, ProQuest: Dissertations and Theses, PsycINFO, Scopus and OpenGrey were searched for research published in English between January 2000 and June 2020. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Cyberbullying involvement, parental support, and cannabis use among adolescents.

Authors:
Hugues Sampasa-Kanyinga Felly Bakwa-Kanyinga Hayley A Hamilton Jean-Philippe Chaput

Child Abuse Negl 2022 Aug 12;133:105830. Epub 2022 Aug 12.

Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Background: Cyberbullying victimization has been associated with cannabis use among adolescents. However, it is unclear if this relationship also holds for cyberbullying perpetrators.

Objective: This cross-sectional study examined the association between cyberbullying involvement and cannabis use among adolescents and tested if parental support was associated with cyberbullying involvement and cannabis use. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap